
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Relationship between miRNA and ferroptosis in tumors
Shang‐Ming Dai, Feng‐Jiao Li, Hui‐Zhi Long, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Shang‐Ming Dai, Feng‐Jiao Li, Hui‐Zhi Long, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1
Mingyang Jiang, Yiji Jike, Kaicheng Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
Mingyang Jiang, Yiji Jike, Kaicheng Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
Targeting ferroptosis: the role of non-coding RNAs in hepatocellular carcinoma progression and therapy
Weijia Wang, Behishta Hashimi, Ping Wang
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
Weijia Wang, Behishta Hashimi, Ping Wang
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
Exploring ferroptosis and miRNAs: implications for cancer modulation and therapy
Mobarakeh Ajam-Hosseini, Sadegh Babashah
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 1
Mobarakeh Ajam-Hosseini, Sadegh Babashah
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 1
Sanggenol L induces ferroptosis in non-small cell lung cancer cells via regulating the miR-26a-1-3p/MDM2/p53 signaling pathway
Rong Fu, Yujie You, Yuqing Wang, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116345-116345
Closed Access | Times Cited: 6
Rong Fu, Yujie You, Yuqing Wang, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116345-116345
Closed Access | Times Cited: 6
The interplay of miRNAs and ferroptosis in diseases related to iron overload
Shikai Jin, Po‐Tsun Liu, Daheng Zheng, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 45-65
Closed Access | Times Cited: 15
Shikai Jin, Po‐Tsun Liu, Daheng Zheng, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 45-65
Closed Access | Times Cited: 15
Modulation of Ferroptosis by microRNAs in Human Cancer
Irena Velkova, Martina Pasino, Zumama Khalid, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 719-719
Open Access | Times Cited: 13
Irena Velkova, Martina Pasino, Zumama Khalid, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 719-719
Open Access | Times Cited: 13
Identification and experimental validation of ferroptosis-related gene lactotransferrin in age-related hearing loss
Chaojun Zeng, Xi Gu, Yuqing Chen, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
Chaojun Zeng, Xi Gu, Yuqing Chen, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
Emerging Insights: miRNA Modulation of Ferroptosis Pathways in Lung Cancer
Elsayed G.E. Elsakka, Heba M. Midan, Ahmed I. Abulsoud, et al.
Experimental Cell Research (2024) Vol. 442, Iss. 2, pp. 114272-114272
Closed Access | Times Cited: 5
Elsayed G.E. Elsakka, Heba M. Midan, Ahmed I. Abulsoud, et al.
Experimental Cell Research (2024) Vol. 442, Iss. 2, pp. 114272-114272
Closed Access | Times Cited: 5
Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy
Jaewang Lee, Jong‐Lyel Roh
Cellular Oncology (2023) Vol. 46, Iss. 6, pp. 1605-1623
Closed Access | Times Cited: 12
Jaewang Lee, Jong‐Lyel Roh
Cellular Oncology (2023) Vol. 46, Iss. 6, pp. 1605-1623
Closed Access | Times Cited: 12
Ferroptosis resistance in cancer: recent advances and future perspectives
Zhang Xing, Xiang Li, Xia Ran, et al.
Biochemical Pharmacology (2023) Vol. 219, pp. 115933-115933
Closed Access | Times Cited: 12
Zhang Xing, Xiang Li, Xia Ran, et al.
Biochemical Pharmacology (2023) Vol. 219, pp. 115933-115933
Closed Access | Times Cited: 12
Ferroptosis: a new promising target for hepatocellular carcinoma therapy
Qiaoping Xu, Lanqi Ren, Ning Ren, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 10, pp. 2615-2636
Closed Access | Times Cited: 12
Qiaoping Xu, Lanqi Ren, Ning Ren, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 10, pp. 2615-2636
Closed Access | Times Cited: 12
Emerging roles of ferroptosis-related miRNAs in tumor metastasis
Zhongyi Jiang, Jing Zhou, Junqi Deng, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Zhongyi Jiang, Jing Zhou, Junqi Deng, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Research Progress on Natural Products That Regulate miRNAs in the Treatment of Osteosarcoma
Guodan Zeng, Xinyu Liu, H. Lv, et al.
Biology (2025) Vol. 14, Iss. 1, pp. 61-61
Open Access
Guodan Zeng, Xinyu Liu, H. Lv, et al.
Biology (2025) Vol. 14, Iss. 1, pp. 61-61
Open Access
Advanced pathological subtype classification of thyroid cancer using efficientNetB0
Hongpeng Guo, Junjie Zhang, You Li, et al.
Diagnostic Pathology (2025) Vol. 20, Iss. 1
Open Access
Hongpeng Guo, Junjie Zhang, You Li, et al.
Diagnostic Pathology (2025) Vol. 20, Iss. 1
Open Access
Glutamine’s double-edged sword: fueling tumor growth and offering therapeutic hope
Liguang Fang, Dandan Gao, Zhe Jiang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Liguang Fang, Dandan Gao, Zhe Jiang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell death
Mohammad Taghizadieh, Mina Kalantari, Roksana Bakhshali, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Mohammad Taghizadieh, Mina Kalantari, Roksana Bakhshali, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
The important role of miR-1-3p in cancers
Shang‐Ming Dai, Fengjiao Li, Shuo‐Guo Xu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Shang‐Ming Dai, Fengjiao Li, Shuo‐Guo Xu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Ferroptosis-related exosomal non-coding RNAs: promising targets in pathogenesis and treatment of non-malignant diseases
Yiping Zhang, Jun Xie
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Yiping Zhang, Jun Xie
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Ferroptosis-Regulated Natural Products and miRNAs and Their Potential Targeting to Ferroptosis and Exosome Biogenesis
Ya-Ting Chuang, Ching‐Yu Yen, Tsu‐Ming Chien, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6083-6083
Open Access | Times Cited: 3
Ya-Ting Chuang, Ching‐Yu Yen, Tsu‐Ming Chien, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6083-6083
Open Access | Times Cited: 3
LINC02086 inhibits ferroptosis and promotes malignant phenotypes of pancreatic cancer via miR-342-3p/CA9 axis
Yuanpeng Xiong, Xiaoyu Kong, Shu‐Ju Tu, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 2
Closed Access | Times Cited: 2
Yuanpeng Xiong, Xiaoyu Kong, Shu‐Ju Tu, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 2
Closed Access | Times Cited: 2
miR-99b/let-7e/miR-125a cluster suppresses pancreatic cancer through regulation of NR6A1
Yaoqing Li
American Journal of Cancer Research (2024) Vol. 14, Iss. 1, pp. 114-129
Open Access | Times Cited: 2
Yaoqing Li
American Journal of Cancer Research (2024) Vol. 14, Iss. 1, pp. 114-129
Open Access | Times Cited: 2
Research status and potential applications of circRNAs affecting colorectal cancer by regulating ferroptosis
Xiyuan Liang, Linna Long, Fan Guan, et al.
Life Sciences (2024) Vol. 352, pp. 122870-122870
Closed Access | Times Cited: 2
Xiyuan Liang, Linna Long, Fan Guan, et al.
Life Sciences (2024) Vol. 352, pp. 122870-122870
Closed Access | Times Cited: 2
Targeting ferroptosis by natural products in pathophysiological conditions
Daheng Zheng, Shikai Jin, Po‐Tsun Liu, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 10, pp. 3191-3208
Closed Access | Times Cited: 2
Daheng Zheng, Shikai Jin, Po‐Tsun Liu, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 10, pp. 3191-3208
Closed Access | Times Cited: 2
Ferroptosis meets microRNAs: a new frontier in anti-cancer therapy
J N Ghosal, V K Sinchana, Sanjiban Chakrabarty
Free Radical Biology and Medicine (2024)
Open Access | Times Cited: 2
J N Ghosal, V K Sinchana, Sanjiban Chakrabarty
Free Radical Biology and Medicine (2024)
Open Access | Times Cited: 2
M2 macrophage exosomes promote resistance to sorafenib in hepatocellular carcinoma cells via miR-200c-3p
Wenhua Li, Bin Zhao, Qianwen Wang, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112807-112807
Closed Access | Times Cited: 1
Wenhua Li, Bin Zhao, Qianwen Wang, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112807-112807
Closed Access | Times Cited: 1